Hang Seng Index & Eli Lilly and Company
4 shared events · Importance 3 · Last updated Jun 11, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
NewsDesk Dashboard
Business
Hang Seng Index: Hong Kong's Hang Seng showed modest gains, but later lost ground, indicating a mixed performance compared to other Asian markets.
Eli Lilly and Company: Eli Lilly and Company>>> advanced after positive trial results for its next-generation obesity drug, retatrutide, which showed benefits beyond weight loss.
May 20, 2026 · 66 articles
International
Hang Seng Index: The Hang Seng Index in Hong Kong rose, reflecting the broader positive trend in Asian stock markets.
Eli Lilly and Company: Eli Lilly and Company>>> advanced after CVS Health>>> announced it would restore coverage for its weight-loss injection, Zepbound, and add its new obesity pill Foundayo.
May 18, 2026 · 309 articles
International
Hang Seng Index: The Hang Seng Index in Hong Kong rose, reflecting the broader positive trend in Asian stock markets.
Eli Lilly and Company: Eli Lilly and Company>>> advanced after CVS Health>>> announced it would restore coverage for its weight-loss injection, Zepbound, and add its new obesity pill Foundayo.
May 27, 2026 · 101 articles
NEWSDESK
Explore this relationship live
Track how Hang Seng Index and Eli Lilly and Company interact across events, view sentiment trends, and discover connected entities.
Open Dashboard